BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17319838)

  • 21. The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion.
    Sachs UJ
    Transfus Apher Sci; 2007 Dec; 37(3):273-82. PubMed ID: 18036987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-related acute lung injury: report of a clinical look-back investigation.
    Kopko PM; Marshall CS; MacKenzie MR; Holland PV; Popovsky MA
    JAMA; 2002 Apr; 287(15):1968-71. PubMed ID: 11960539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human neutrophil antibodies in a blood donor population: a lookback study.
    Gottschall J; Triulzi D; Kakaiya R; Carrick D; Roback JD; Carey P; Kleinman S;
    Vox Sang; 2013 Feb; 104(2):166-70. PubMed ID: 22998453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.
    Rana R; Fernández-Pérez ER; Khan SA; Rana S; Winters JL; Lesnick TG; Moore SB; Gajic O
    Transfusion; 2006 Sep; 46(9):1478-83. PubMed ID: 16965572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-related acute lung injury: an update.
    Triulzi DJ
    Hematology Am Soc Hematol Educ Program; 2006; ():497-501. PubMed ID: 17124105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent transfusion-related acute lung injury after a two-year interval.
    Krochmal JD; Dwyre DM; Swanson KM; Raife TJ; Schlueter AJ
    Transfus Med; 2007 Jun; 17(3):192-6. PubMed ID: 17561861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-related acute lung injury.
    Gajic O; Moore SB
    Mayo Clin Proc; 2005 Jun; 80(6):766-70. PubMed ID: 15945528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
    Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
    Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-related alloimmune neutropenia with no pulmonary complications: one donor-five cases.
    Hauck-Dlimi B; Ruppel R; Zimmermann R; Strobel J; Reil A; Eckstein R; Zingsem J
    Transfusion; 2016 Jan; 56(1):84-90. PubMed ID: 26388439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative pulmonary edema, transfusion-related?--a case report.
    Chung YT; Wu YC; Chen YH
    Acta Anaesthesiol Sin; 2003 Mar; 41(1):43-6. PubMed ID: 12747347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
    Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
    Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The two-event model of transfusion-related acute lung injury.
    Silliman CC
    Crit Care Med; 2006 May; 34(5 Suppl):S124-31. PubMed ID: 16617256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are we missing reverse TRALI? - A real world experience from a tertiary care oncology centre in India.
    Basu D; Basu S; Datta SS
    Transfus Apher Sci; 2022 Dec; 61(6):103466. PubMed ID: 35654712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ; Kauschat D; Bein G
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary consequences of transfusion: TRALI and TACO.
    Popovsky MA
    Transfus Apher Sci; 2006 Jun; 34(3):243-4. PubMed ID: 16872902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.
    Enright H; Davis K; Gernsheimer T; McCullough JJ; Woodson R; Slichter SJ
    Transfusion; 2003 Nov; 43(11):1545-52. PubMed ID: 14617313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.
    Davoren A; Curtis BR; Shulman IA; Mohrbacher AF; Bux J; Kwiatkowska BJ; McFarland JG; Aster RH
    Transfusion; 2003 May; 43(5):641-5. PubMed ID: 12702187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary injury from transfusion-related acute lung injury.
    Kopko PM; Popovsky MA
    Clin Chest Med; 2004 Mar; 25(1):105-11. PubMed ID: 15062602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.